Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B: GSK Ruchika Sharma3 Sept 2024 9:30 AM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted SENKU (formerly known as SAKIGAKE)...
Submit details of adverse events reported: CDSCO Panel Tells GSK on Mepolizumab Powder for Solution for Injection Dr. Divya Colin24 Aug 2024 6:00 PM ISTNew Delhi: In line with the Phase IV clinical trial report of the monoclonal antibody Mepolizumab (Brand Name: Nucala 100 mg) presented by the drug...
GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer Ruchika Sharma21 Aug 2024 11:30 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...
US FDA expands Jemperli plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma2 Aug 2024 10:00 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and...
Blenrep combinations in multiple myeloma application accepted for review by EMA: GSK Ruchika Sharma20 July 2024 3:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for...
GlaxoSmithKline Pharma appoints Dr Shalini Menon as Executive Vice President - Medical Affairs Ruchika Sharma5 July 2024 4:53 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has appointed Dr. Shalini Menon as Executive Vice President - Medical Affairs, effective 8th...
GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk Ruchika Sharma9 Jun 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...
GSK acquires Elsie Biotechnologies for up to USD 50 million Ruchika Sharma7 Jun 2024 4:22 PM ISTLondon: GSK plc has announced that it has acquired Elsie Biotechnologies, a San Diego-based private biotechnology company working on unlocking the...
GSK disagrees with ruling by Delaware State Court on ranitidine litigation, to seek appeal Ruchika Sharma3 Jun 2024 2:41 PM ISTLondon: GSK plc has announced that it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal. The decision by...
Zantac not a cause of woman's cancer, says jury Ruchika Sharma24 May 2024 3:34 PM ISTChicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the discontinued...
GSK raises USD 1.5 billion from sale of remaining Haleon stake Ruchika Sharma19 May 2024 11:30 AM ISTGSK sold around 385 million shares at 324 pence each, amounting to a 4.2 per cent stake in Haleon.
